Mefloquine during the study. Mefloquine was the first Public-Private Venture (PPV) between the US Department of Defense and a pharmaceutical company. WRAIR transferred all its phase I and phase II clinical trial data to Hoffman LaRoche and Smith Kline. FDA approval as a treatment for malaria was swift. Most notably, phase III safety and tolerability trials were skipped. The drug was first approved and sold on a commercial basis in Switzerland in 1985. However, mefloquine was not approved by the FDA for prophylactic use until 1989. This approval was based primarily on compliance, while safety and tolerability were overlooked. Because of
International Association for the Treatment of Sexual Offenders either individual, couple, family, or even group settings. The treatments offered are created and used to prevent any offending behavior and further victimization of others. The biomedical treatment is the use of pharmacological treatment. This type of therapy in the past has included the use of anti-androgens, antidepressants, and anti-anxiety, anti epileptic, antipsychotic, or other types of medicine. However, note that biomedical treatment is not limited to these medications. All medications have different turnouts for different individuals, so it is crucial to find the best fit and the most successful medication for that specific person to help treat them and